ID   CCNL1_HUMAN             Reviewed;         526 AA.
AC   Q9UK58; B3KMY3; C9JPL0; Q6NVY9; Q6UWS7; Q8NI48; Q96QT0; Q9NZF3;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   07-APR-2021, entry version 175.
DE   RecName: Full=Cyclin-L1;
DE            Short=Cyclin-L;
GN   Name=CCNL1; ORFNames=BM-001, UNQ530/PRO1073;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), FUNCTION, TISSUE
RP   SPECIFICITY, DOMAIN, AND INTERACTION WITH CDC2L AND SFRS2.
RC   TISSUE=Lung;
RX   PubMed=11980906; DOI=10.1074/jbc.m202266200;
RA   Dickinson L.A., Edgar A.J., Ehley J., Gottesfeld J.M.;
RT   "Cyclin L is an RS domain protein involved in pre-mRNA splicing.";
RL   J. Biol. Chem. 277:25465-25473(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Lung, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 204-526 (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 226-526 (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12414649;
RA   Redon R., Hussenet T., Bour G., Caulee K., Jost B., Muller D.,
RA   Abecassis J., du Manoir S.;
RT   "Amplicon mapping and transcriptional analysis pinpoint cyclin L as a
RT   candidate oncogene in head and neck cancer.";
RL   Cancer Res. 62:6211-6217(2002).
RN   [9]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15700036; DOI=10.1038/sj.bjc.6602400;
RA   Sticht C., Hofele C., Flechtenmacher C., Bosch F.X., Freier K., Lichter P.,
RA   Joos S.;
RT   "Amplification of Cyclin L1 is associated with lymph node metastases in
RT   head and neck squamous cell carcinoma (HNSCC).";
RL   Br. J. Cancer 92:770-774(2005).
RN   [10]
RP   FUNCTION, IDENTIFICATION OF ISOFORMS 1; 2 AND 3, INTERACTION WITH CDK11B;
RP   CKII; SRSF1 AND SRSF7/SLU7, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18216018; DOI=10.1074/jbc.m708188200;
RA   Loyer P., Trembley J.H., Grenet J.A., Busson A., Corlu A., Zhao W.,
RA   Kocak M., Kidd V.J., Lahti J.M.;
RT   "Characterization of cyclin L1 and L2 interactions with CDK11 and splicing
RT   factors: influence of cyclin L isoforms on splice site selection.";
RL   J. Biol. Chem. 283:7721-7732(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-325; SER-335 AND SER-338, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335; SER-338 AND SER-352, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335; SER-352 AND SER-445, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352; SER-355 AND SER-374, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-362, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339 AND LYS-347, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Involved in pre-mRNA splicing. Functions in association with
CC       cyclin-dependent kinases (CDKs) (PubMed:18216018). Inhibited by the
CC       CDK-specific inhibitor CDKN1A/p21 (PubMed:11980906). May play a role in
CC       the regulation of RNA polymerase II (pol II). May be a candidate proto-
CC       oncogene in head and neck squamous cell carcinomas (HNSCC)
CC       (PubMed:12414649, PubMed:15700036). {ECO:0000269|PubMed:11980906,
CC       ECO:0000269|PubMed:12414649, ECO:0000269|PubMed:15700036,
CC       ECO:0000269|PubMed:18216018}.
CC   -!- SUBUNIT: Interacts with POLR2A via its hyperphosphorylated C-terminal
CC       domain (CTD) (By similarity). Interacts with CDK11A, CDK12 and CDK13
CC       (PubMed:11980906, PubMed:18216018). Isoforms 1 and 2, but not isoform
CC       3, interact with CDK11B. May form a ternary complex with CDK11B and
CC       casein kinase II (CKII) (PubMed:18216018). Interacts with pre-mRNA-
CC       splicing factors, including at least SRSF1, SRSF2 AND SRSF7/SLU7
CC       (PubMed:11980906, PubMed:18216018). {ECO:0000250|UniProtKB:Q9R1Q2,
CC       ECO:0000269|PubMed:11980906, ECO:0000269|PubMed:18216018}.
CC   -!- INTERACTION:
CC       Q9UK58; Q92624: APPBP2; NbExp=3; IntAct=EBI-2836773, EBI-743771;
CC       Q9UK58; Q6NVI2: CASP8; NbExp=3; IntAct=EBI-2836773, EBI-12861768;
CC       Q9UK58; Q92997: DVL3; NbExp=3; IntAct=EBI-2836773, EBI-739789;
CC       Q9UK58; Q8N9E0: FAM133A; NbExp=3; IntAct=EBI-2836773, EBI-10268158;
CC       Q9UK58; P59991: KRTAP12-2; NbExp=3; IntAct=EBI-2836773, EBI-10176379;
CC       Q9UK58; Q9BU76: MMTAG2; NbExp=3; IntAct=EBI-2836773, EBI-742459;
CC       Q9UK58; Q6ZUT1: NKAPD1; NbExp=6; IntAct=EBI-2836773, EBI-3920396;
CC       Q9UK58; Q9NQX0: PRDM6; NbExp=3; IntAct=EBI-2836773, EBI-11320284;
CC       Q9UK58; O75400-2: PRPF40A; NbExp=3; IntAct=EBI-2836773, EBI-5280197;
CC       Q9UK58; O75771: RAD51D; NbExp=3; IntAct=EBI-2836773, EBI-1055693;
CC       Q9UK58; Q15287: RNPS1; NbExp=4; IntAct=EBI-2836773, EBI-395959;
CC       Q9UK58; Q9BUV0: RSRP1; NbExp=3; IntAct=EBI-2836773, EBI-745604;
CC       Q9UK58; Q9UHR5: SAP30BP; NbExp=3; IntAct=EBI-2836773, EBI-751683;
CC       Q9UK58; O60504: SORBS3; NbExp=3; IntAct=EBI-2836773, EBI-741237;
CC       Q9UK58; Q8N9Q2: SREK1IP1; NbExp=3; IntAct=EBI-2836773, EBI-10268630;
CC       Q9UK58; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-2836773, EBI-1105213;
CC       Q9UK58; Q9UGI0: ZRANB1; NbExp=3; IntAct=EBI-2836773, EBI-527853;
CC       Q9UK58; Q15696: ZRSR2; NbExp=3; IntAct=EBI-2836773, EBI-6657923;
CC       Q9UK58-5; O94985-2: CLSTN1; NbExp=3; IntAct=EBI-25873837, EBI-16041593;
CC       Q9UK58-5; P13473-2: LAMP2; NbExp=3; IntAct=EBI-25873837, EBI-21591415;
CC       Q9UK58-5; O75400-2: PRPF40A; NbExp=3; IntAct=EBI-25873837, EBI-5280197;
CC       Q9UK58-5; Q9Y371: SH3GLB1; NbExp=3; IntAct=EBI-25873837, EBI-2623095;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:18216018}.
CC       Nucleus, nucleoplasm {ECO:0000269|PubMed:18216018}. Note=Found in
CC       nuclear intrachromatin granules clusters (IGC), also called nuclear
CC       speckles, which are storage compartments for nuclear proteins involved
CC       in mRNA processing. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Ccnl1 is an immediate-early gene with independently regulated
CC         isoforms.;
CC       Name=1; Synonyms=Cyclin L alpha, cyclin L1alpha;
CC         IsoId=Q9UK58-1; Sequence=Displayed;
CC       Name=2; Synonyms=Cyclin L beta, cyclin L1beta;
CC         IsoId=Q9UK58-4; Sequence=VSP_016122, VSP_016123;
CC       Name=3; Synonyms=Cyclin L gamma, cyclin L1gamma;
CC         IsoId=Q9UK58-5; Sequence=VSP_016120, VSP_016121;
CC       Name=4;
CC         IsoId=Q9UK58-6; Sequence=VSP_058299, VSP_058300;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Overexpression in primary tumors
CC       of head and neck squamous cell carcinomas (HNSCC).
CC       {ECO:0000269|PubMed:11980906, ECO:0000269|PubMed:12414649,
CC       ECO:0000269|PubMed:15700036, ECO:0000269|PubMed:18216018}.
CC   -!- DOMAIN: Contains a RS region (arginine-serine dipeptide repeat) within
CC       the C-terminal domain which is the hallmark of the SR family of
CC       splicing factors. This region probably plays a role in protein-protein
CC       interactions. {ECO:0000269|PubMed:11980906}.
CC   -!- MISCELLANEOUS: CCNL1 is amplified in several HNSCC. May play a critical
CC       role in the formation of loco-regional metastases and an unfavorable
CC       clinical outcome of HNSCC.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the cyclin family. Cyclin L subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF64257.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=AAQ89026.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF180920; AAD53184.1; -; mRNA.
DR   EMBL; AF367476; AAM21204.1; -; mRNA.
DR   EMBL; AF367477; AAM21205.1; -; mRNA.
DR   EMBL; AY034790; AAK61551.1; -; mRNA.
DR   EMBL; AK022974; BAG51145.1; -; mRNA.
DR   EMBL; AK122738; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC104411; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78712.1; -; Genomic_DNA.
DR   EMBL; BC007081; AAH07081.1; -; mRNA.
DR   EMBL; BC038394; AAH38394.1; -; mRNA.
DR   EMBL; BC067812; AAH67812.1; -; mRNA.
DR   EMBL; AF208843; AAF64257.1; ALT_SEQ; mRNA.
DR   EMBL; AY358663; AAQ89026.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS3178.1; -. [Q9UK58-1]
DR   CCDS; CCDS77847.1; -. [Q9UK58-6]
DR   RefSeq; NP_001295114.1; NM_001308185.1. [Q9UK58-6]
DR   RefSeq; NP_064703.1; NM_020307.3. [Q9UK58-1]
DR   RefSeq; XP_016862381.1; XM_017006892.1.
DR   RefSeq; XP_016862382.1; XM_017006893.1.
DR   RefSeq; XP_016862383.1; XM_017006894.1.
DR   RefSeq; XP_016862384.1; XM_017006895.1.
DR   RefSeq; XP_016862385.1; XM_017006896.1.
DR   SMR; Q9UK58; -.
DR   BioGRID; 121327; 33.
DR   ComplexPortal; CPX-341; Cyclin L1-CDK11A(p110) complex.
DR   ComplexPortal; CPX-344; Cyclin L1-CDK11A(p58) complex.
DR   ComplexPortal; CPX-346; Cyclin L1-CDK11B(p58) complex.
DR   ComplexPortal; CPX-348; Cyclin L1-CDK11B(p110) complex.
DR   IntAct; Q9UK58; 44.
DR   MINT; Q9UK58; -.
DR   STRING; 9606.ENSP00000295926; -.
DR   iPTMnet; Q9UK58; -.
DR   PhosphoSitePlus; Q9UK58; -.
DR   BioMuta; CCNL1; -.
DR   DMDM; 74753368; -.
DR   EPD; Q9UK58; -.
DR   jPOST; Q9UK58; -.
DR   MassIVE; Q9UK58; -.
DR   PaxDb; Q9UK58; -.
DR   PeptideAtlas; Q9UK58; -.
DR   PRIDE; Q9UK58; -.
DR   ProteomicsDB; 11129; -.
DR   ProteomicsDB; 84724; -. [Q9UK58-1]
DR   ProteomicsDB; 84725; -. [Q9UK58-4]
DR   ProteomicsDB; 84726; -. [Q9UK58-5]
DR   Antibodypedia; 18411; 219 antibodies.
DR   Ensembl; ENST00000295925; ENSP00000295925; ENSG00000163660. [Q9UK58-5]
DR   Ensembl; ENST00000295926; ENSP00000295926; ENSG00000163660. [Q9UK58-1]
DR   Ensembl; ENST00000461804; ENSP00000420277; ENSG00000163660. [Q9UK58-6]
DR   Ensembl; ENST00000465947; ENSP00000418094; ENSG00000163660. [Q9UK58-5]
DR   Ensembl; ENST00000470121; ENSP00000417237; ENSG00000163660. [Q9UK58-4]
DR   Ensembl; ENST00000475298; ENSP00000417343; ENSG00000163660. [Q9UK58-5]
DR   Ensembl; ENST00000477127; ENSP00000418449; ENSG00000163660. [Q9UK58-5]
DR   Ensembl; ENST00000631619; ENSP00000487951; ENSG00000163660. [Q9UK58-5]
DR   GeneID; 57018; -.
DR   KEGG; hsa:57018; -.
DR   UCSC; uc003fbd.2; human.
DR   UCSC; uc003fbf.4; human. [Q9UK58-1]
DR   CTD; 57018; -.
DR   DisGeNET; 57018; -.
DR   GeneCards; CCNL1; -.
DR   HGNC; HGNC:20569; CCNL1.
DR   HPA; ENSG00000163660; Low tissue specificity.
DR   MIM; 613384; gene.
DR   neXtProt; NX_Q9UK58; -.
DR   OpenTargets; ENSG00000163660; -.
DR   PharmGKB; PA134980948; -.
DR   VEuPathDB; HostDB:ENSG00000163660.11; -.
DR   eggNOG; KOG0835; Eukaryota.
DR   GeneTree; ENSGT00940000159135; -.
DR   HOGENOM; CLU_107641_0_0_1; -.
DR   InParanoid; Q9UK58; -.
DR   OMA; INFIYQA; -.
DR   OrthoDB; 1519153at2759; -.
DR   PhylomeDB; Q9UK58; -.
DR   TreeFam; TF101011; -.
DR   PathwayCommons; Q9UK58; -.
DR   SignaLink; Q9UK58; -.
DR   BioGRID-ORCS; 57018; 332 hits in 1003 CRISPR screens.
DR   ChiTaRS; CCNL1; human.
DR   GeneWiki; CCNL1; -.
DR   GenomeRNAi; 57018; -.
DR   Pharos; Q9UK58; Tbio.
DR   PRO; PR:Q9UK58; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9UK58; protein.
DR   Bgee; ENSG00000163660; Expressed in bone marrow and 234 other tissues.
DR   ExpressionAtlas; Q9UK58; baseline and differential.
DR   Genevisible; Q9UK58; HS.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006396; P:RNA processing; IEA:InterPro.
DR   CDD; cd00043; CYCLIN; 2.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR043198; Cyclin/Ssn8.
DR   InterPro; IPR004367; Cyclin_C-dom.
DR   InterPro; IPR015431; Cyclin_L1.
DR   InterPro; IPR006671; Cyclin_N.
DR   PANTHER; PTHR10026; PTHR10026; 1.
DR   PANTHER; PTHR10026:SF64; PTHR10026:SF64; 1.
DR   Pfam; PF02984; Cyclin_C; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SMART; SM01332; Cyclin_C; 1.
DR   SUPFAM; SSF47954; SSF47954; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cyclin; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Proto-oncogene; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..526
FT                   /note="Cyclin-L1"
FT                   /id="PRO_0000080480"
FT   REGION          88..190
FT                   /note="Cyclin-like 1"
FT   REGION          203..287
FT                   /note="Cyclin-like 2"
FT   REGION          390..432
FT                   /note="RS"
FT   MOD_RES         325
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231"
FT   MOD_RES         338
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         352
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         355
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         374
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         445
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   CROSSLNK        339
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        347
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        362
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25755297"
FT   VAR_SEQ         163..172
FT                   /note="RTPSPLILDQ -> SDQLHLPKPG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11980906"
FT                   /id="VSP_016120"
FT   VAR_SEQ         173..526
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11980906"
FT                   /id="VSP_016121"
FT   VAR_SEQ         226..232
FT                   /note="NYMNDSL -> VVHDGKS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11980906"
FT                   /id="VSP_016122"
FT   VAR_SEQ         233..526
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11980906"
FT                   /id="VSP_016123"
FT   VAR_SEQ         411..428
FT                   /note="HYNNRRSRSGTYSSRSRS -> QDEVLLRCPGRSRTPGLK (in isoform
FT                   4)"
FT                   /id="VSP_058299"
FT   VAR_SEQ         429..526
FT                   /note="Missing (in isoform 4)"
FT                   /id="VSP_058300"
FT   CONFLICT        149
FT                   /note="V -> L (in Ref. 5; AAH67812)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        507..508
FT                   /note="RS -> SP (in Ref. 6; AAF64257)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   526 AA;  59634 MW;  64C0CAEF54A3E9F9 CRC64;
     MASGPHSTAT AAAAASSAAP SAGGSSSGTT TTTTTTTGGI LIGDRLYSEV SLTIDHSLIP
     EERLSPTPSM QDGLDLPSET DLRILGCELI QAAGILLRLP QVAMATGQVL FHRFFYSKSF
     VKHSFEIVAM ACINLASKIE EAPRRIRDVI NVFHHLRQLR GKRTPSPLIL DQNYINTKNQ
     VIKAERRVLK ELGFCVHVKH PHKIIVMYLQ VLECERNQTL VQTAWNYMND SLRTNVFVRF
     QPETIACACI YLAARALQIP LPTRPHWFLL FGTTEEEIQE ICIETLRLYT RKKPNYELLE
     KEVEKRKVAL QEAKLKAKGL NPDGTPALST LGGFSPASKP SSPREVKAEE KSPISINVKT
     VKKEPEDRQQ ASKSPYNGVR KDSKRSRNSR SASRSRSRTR SRSRSHTPRR HYNNRRSRSG
     TYSSRSRSRS RSHSESPRRH HNHGSPHLKA KHTRDDLKSS NRHGHKRKKS RSRSQSKSRD
     HSDAAKKHRH ERGHHRDRRE RSRSFERSHK SKHHGGSRSG HGRHRR
//
